Skip to main content
Premium Trial:

Request an Annual Quote

Cynvenio Biosystems Raises $25.5M in Series B Round

NEW YORK (GenomeWeb) – Cynvenio Biosystems announced today that it has raised $25.5 million in a Series B financing round. The money will help the company advance the clinical development and commercialization of its LiquidBiopsy platform, which allows analysis of both circulating tumor cells and circulating cell-free tumor DNA.

China-based Livzon Pharmaceutical Group led the funding round. Other investors included Greenwoods Private Equity Funds in Shanghai and Syno Capital in New York.

Cynvenio CEO André de Fusco said in a statement that concurrent to the Series B funding, Cynvenio is establishing a China-based joint venture with Livzon Pharma's diagnostics subsidiary, supported by an additional $10 million in operating capital.

Desheng Tao, president of Livzon Pharmaceutical Group, said in a statement that Livzon Diagnostics plans to "quickly bring LiquidBiopsy to all hospitals and research institutions in greater China."

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.